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The General Infirmary at Leeds, Leeds, UKObjectives. Ischaemia modified albumin (IMA) has been used as a marker of myocardial ischaemia but little is known about
its production during ischaemia of other tissues. The clinical models of patients with intermittent claudication and major
arterial surgery were used to investigate IMA production from ischaemic skeletal muscle.
Design. Prospective clinical study.
Materials and methods. IMA was measured pre-operatively, at end ischaemia, and 5 min, 4, 24, 48, 72 and 144 h post-
surgery in patients undergoing (a) revascularisation for intermittent claudication (IC, nZ15), (b) abdominal aortic
aneurysm repair (AAA, nZ12) and controls (nZ16).
Results. The median pre-operative IMA concentration in IC patients was significantly higher than the AAA group (88.3
versus 83.5 U/ml, pZ0.036) and controls (88.3 versus 80.3 U/ml, pZ0.031). IMA concentrations increased significantly
during arterial clamping in both IC and AAA groups (88.3 versus 120.0 U/ml, pZ0.001; 83.5 versus 118.8 U/ml, pZ
0.002, respectively) consistent with increased skeletal muscle ischaemia. In contrast, there was only a mild perioperative
increase in the controls (80.3 versus 91.6 U/ml, pZ0.012).
Conclusions. Patients with intermittent claudication have significantly elevated IMA and skeletal muscle ischaemia
during arterial surgery results in significantly increased circulating IMA. When IMA is used to detect myocardial
ischaemia, ischaemic skeletal muscle must be excluded.Keywords: Serum albumin; Ischemia; Muscle, skeletal.Introduction
Ischaemia, from disparate causes, is a common
event in the pathogenesis of a wide variety of
medical and surgical conditions including myocar-
dial infarction, mesenteric vascular occlusion and
compartment syndrome. The diagnosis of disorders
such as these is often clinical, requiring the
detection of subtle symptoms and signs for timely
intervention.1,2 Despite years of research, a ‘gold
standard’ test for ischaemia, that may guide clinical
diagnosis, remains elusive. Lactate production from
anaerobic metabolism may be measured by a point
of care test, yet is rarely used outside the confines
of the intensive care unit. Other biochemical
markers include creatine kinase, myoglobin and
the troponins. However, their release requires
significant cellular injury and membrane disruption,ing author. M. Troxler, MBChB, MRCS, Vascular
, The General Infirmary at Leeds, Great George Street,
orkshire LS1 3EX, UK.
: maxtrox@supanet.com
0164 + 06 $35.00/0 q 2005 Published by Elsevier Ltd.so are usually considered to be markers of necrosis
rather than ischaemia.3–5
The pathophysiological events of ischaemia, includ-
ing hypoxia, acidosis and free radical generation,
result in a conformational change of the N-terminus of
albumin, leading to a reduction in its binding of the
transition metals copper, nickel and cobalt.6,7 The
resulting molecule has been termed Ischaemia Modi-
fied Albumin (IMAe) and its reduced binding of
cobalt has been exploited to produce a rapid,
automated test, the Albumin Cobalt Bindinge assay.8
To date, clinical research has focused on IMA in
patients attending the Accident and Emergency Depart-
ment with possible myocardial ischaemia. It has been
shown that IMA measurement on presentation can
predict a subsequent troponin rise with a high negative
predictive value, allowing its use for the triage of
patients with chest pain.6 In contrast to coronary artery
disease, there has been relatively little investigation of
IMA generation during ischaemia of other tissues. The
aim of this study was to measure IMA concentrations in
the presence of ischaemic skeletal muscle.Eur J Vasc Endovasc Surg 31, 164–169 (2006)
doi:10.1016/j.ejvs.2005.06.019, available online at http://www.sciencedirect.com on
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involving ischaemic skeletal muscle is intermittent
claudication (IC) due to peripheral arterial disease.
During exercise, patients with intermittent claudica-
tion are exposed to repeated episodes of symptom-
inducing lower limb ischaemia. More profound
skeletal muscle ischaemia occurs during arterial
surgery secondary to the application of vascular
clamps. IMA was measured pre- and peri-operatively
in patients with IC undergoing lower limb revascular-
isation, in patients exposed to bilateral lower limb
ischaemia from aortic cross-clamping required for
abdominal aortic aneurysm (AAA) repair and in a
control group consisting of patients undergoing
operative repair of varicose veins.Materials and Methods
All study procedures were approved by the local
ethics committee and written, informed consent was
obtained. Twelve consecutive patients attending for
elective open transperitoneal AAA repair and 19
patients with peripheral arterial disease causing
intermittent claudication were enrolled in the study.
Demographic data are shown in Table 1. Peripheral
arterial disease was confirmed by an ankle-brachial
pressure index !0.8 and angiographically or duplex
ultrasound proven occlusion or stenosis of the iliac,
femoral or popliteal arteries. Patients with peripheral
arterial disease had no AAA to palpation and patients
with AAA had no symptoms of peripheral arterial
disease. None of the patients with vascular disease
had suffered a myocardial infarction or acute coronary
syndrome in the preceding 6 months. Sixteen aged-
matched controls with symptomatic varicose veins
were also recruited.
All 12 patients with AAA were treated with surgical
reconstruction whilst 15 of the claudicants underwent
operative lower limb arterial revascularisation.
General anaesthesia was used in all cases and upper
limb venous blood samples were obtained pre-
operatively, intraoperatively just before removal ofTable 1. Demographic details of the patients with AAA, intermittent
Parameter AAA Claudicants
n 12 19
Median age, years (IQR) 74* (70–75) 68* (58–76)
Sex (F:M) 1:11 5:14
Current smokers 4 4
Hypertension 8 11
Diabetes mellitus 2 4
Hypercholesterolaemia 4 8
* Kruskal–Wallis: pZ0.134.the vascular clamp(s) (end ischaemia), and then 5 min
after clamp removal (reperfusion). Further samples
were taken after 4, 24, 48, 72 and 144 h of reperfusion.
Likewise, eight of the control patients underwent
operative repair of their varicose veins and peripheral
blood samples were taken pre-operatively, intraopera-
tively (i.e. 30 min post-skin incision) and then at 4, 24,
48, 72 and 144 h post-surgery. Blood was taken with
the use of an elastic tourniquet using minimal tension,
well below even arterial diastolic pressure. Pre-
operative samples were taken following at least
30 min rest, and at all time points blood was drawn
into plain tubes (Sarstedt, Numbrecht, Germany) and
then centrifuged at 2500g for 15 min within 1 h of
collection. The serum supernatant was then stored in
aliquots in polypropylene tubes (Sarstedt) at K80 8C
and IMA later measured by the Albumin Cobalt
Binding assay (Ischaemia Technologies Inc., Denver,
USA) on a COBAS MIRA Plus analyser (ABX
Diagnostics, Shefford, UK) and expressed in U/ml. A
cardiac troponin I assay (Accu TnI, Beckman Coulter,
High Wycombe, UK) was also performed 24 h post-
operatively in all patients under going surgery and a
value above 0.3 ng/ml was considered to be the result
of myocardial injury.
The data were analysed using SPSS version 10.1 and
results are expressed as medians and inter-quartile
ranges. Further analysis of the data was carried out
using non-parametric tests. Inter-group variation was
assessed by the Mann–Whitney U-test for paired
comparisons and the Kruskal–Wallis test for multiple
comparisons. Repeated measures over time were
assessed with the Friedman two-way analysis of
variance and the Wilcoxon signed ranks test.Results
The pre-operative IMA concentrations for the patients
with AAA, intermittent claudication and control
groups are shown in Fig. 1. Significant differences in
the pre-operative IMA concentrations were observed
between the three groups of subjects. Claudicantsclaudication and controls
Controls Controls undergoing
surgery
16 8
67* (54–76) 60* (32–68)
4:12 4:4
2 0
3 0
0 0
1 0
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Fig. 1. Pre-operative IMA concentrations in patients with AAA, claudicants and controls (median and interquartile range).
Kruskal–Wallis: pZ0.046; Mann–Whitney: *pZ0.018 and †pZ0.025 versus claudicants.
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serum IMA (88.3 U/ml). This was significantly greater
than that of the AAA group (83.5 U/ml; pZ0.036). The
concentration of circulating IMA in claudicants was
also significantly higher than that found in controls
(80.3 U/ml; pZ0.031) and above the reference value of
less than 85 U/ml quoted by the manufacturer. There
was no significant difference in IMA between patients
with AAA and the control group.
In the patients undergoing varicose vein surgery, who
did not undergo any specific skeletal muscle ischaemia
but did undergo general anaesthesia, there was a small
but significant intraoperative rise in IMA concentration
(80.3 versus 91.6 U/ml intraoperatively, pZ0.012)Fig. 2. Perioperative IMA concentrations in patients receiving v
pZ0.003; Wilcoxon rank: *pZ0.012 versus pre-op.
Eur J Vasc Endovasc Surg Vol 31, 2 2006(Fig. 2). Values then returned to baseline within 4–24 h
post-surgery. In contrast, the perioperative temporal
IMA profile of patients undergoing lower limb revascu-
larisation revealed a marked and significant increase
during lower limb ischaemia (88.3 versus 126.5 U/ml at
end ischaemia, pZ0.001) (Fig. 3). There was no
significant change in IMA concentration on reperfusion
and levels remained significantly above baseline for up
to 6 days. A similar profile was seen in patients
undergoing AAA repair with a marked increase in
IMA concentrations during lower torso ischaemia (83.5
versus 118.8 U/ml at end ischaemia, pZ0.002). Again, no
change on reperfusion was detected and levels remained
above baseline for up to 6 days (Fig. 4).aricose vein surgery (median and IQR). Friedman’s ANOVA:
Fig. 3. Perioperative concentrations of IMA in patients undergoing lower limb bypass (median and IQR). Friedman’s
ANOVA: p!0.0001; Wilcoxon rank: *pZ0.001, †p!0.004 versus pre-op.
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difference in IMA concentrations between the patients
undergoing lower limb revascularisation and AAA
repair at the end of ischaemia, on reperfusion or after
4 h of reperfusion, despite the greater volume of
ischaemic tissue in the latter. However, after 24 and
48 h of reperfusion, the median IMA concentration inFig. 4. Perioperative concentrations of IMA in patients recei
p!0.0001; Wilcoxon rank: *pZ0.002, †p!0.008 versus pre-op.the AAA repair group was significantly greater than
the revascularisation group (120.3 versus 112.3 U/ml at
24 h, pZ0.05; 118.0 versus 103.0 U/ml at 48 h, pZ0.007,
respectively). Overall, in the patients receiving arterial
surgery, all intra and post-operative IMA concen-
trations were significantly greater than the equivalent
values in the control group (p!0.001).ving AAA repair (median and IQR). Friedman’s ANOVA:
Eur J Vasc Endovasc Surg Vol 31, 2 2006
M. Troxler et al.168Troponin I was not raised in any of the control
patients. It was raised in two of the patients in the
AAA group (O99.9 and 9.44 ng/ml) and in two
patients in the revascularisation group (0.66 and
7.99 ng/ml). There was no correlation between perio-
perative IMA values and troponin I levels nor was
there any correlation with the duration of arterial
clamping.Discussion
The results of this study indicate that the modified
albumin detected by the albumin cobalt binding assay
is a normal constituent of serum. Though free radicals
are implicated to some degree in almost every disease,
they are also produced as a result of ‘normal’
metabolism and endogenous antioxidants act to
suppress their effects.9,10 The presence of circulating
levels of IMA in control subjects is, therefore, likely to
reflect the endogenous production of free radicals ‘in
health’. In addition, it has been suggested that the
modifications of albumin resulting in decreased
transition metal binding may represent the first steps
in a pathway for the normal degradation of albumin
within the circulation.11
Only two patients in each of the arterial surgery
groups were found to have raised troponin I
suggesting concomitant myocardial cell injury. The
perioperative IMA profile was remarkably consistent
between all patients and did not correlate with the
raised troponin values suggesting that the changes in
IMA were not due to significant myocardial ischaemia.
Apple et al. measured IMA in the context of skeletal
muscle ischaemia/injury in 19 amateur athletes
running a marathon.12 All runners had increased
circulating myoglobin immediately after the race,
with values returning to normal after 24–48 h. Six
had increased troponin-I immediately post-race, with
all but one returning to baseline after 24–48 h. In
contrast, all IMA concentrations were in the normal
range immediately after the race but in 12 athletes,
IMA was elevated above reference values after 24–
48 h. These individuals will, of course, not have flow-
limiting peripheral arterial disease and the normal
IMA values after the race suggest that they have not
been exposed to skeletal muscle ischaemia per se.
However, exhausting exercise of this kind may induce
an inflammatory response and associated swelling so
marked as to induce a lower limb compartment
syndrome.13,14 It is this inflammation that might
have led to the production of IMA.
In keeping with the results in this study, Roy et al.
noted that pre-exercise IMA levels were aboveEur J Vasc Endovasc Surg Vol 31, 2 2006reference values in 26% of patients with intermittent
claudication.15 However, they did not include a
control group for comparison. Despite elevated initial
concentrations of IMA, they noted a reduction in IMA
during treadmill exercise that had returned to base
line by 1 h. Similar results have been reported with a
forearm ischaemia model with IMA increasing to base
line after 30 min.16 This reduction in IMA during
skeletal muscle ischaemia at first appears contrary to
the results of the current study. However, in the
present study, the perioperative samples at the end of
ischaemia were taken between 60 and 90 min after the
application of arterial clamps and this longer period of
ischaemia and later sampling point may explain the
discrepancy.
Patients with intermittent claudication are exposed
to repeated episodes of skeletal muscle ischaemia,
reperfusion and their sequelae. Studies have revealed
that exercise in claudicants induces acute inflamma-
tory events within the muscle, including neutrophil
activation and the production of cytokines and
oxygen-derived free radicals.17–19 The effects of these
pathophysiological processes on serum albumin are
likely to be the cause of the elevated level of circulating
IMA in the claudicant patients in this study.
In a study of 41 patients undergoing coronary
angioplasty, IMA levels increased by a mean of 10.1%
immediately after the last balloon inflation.20 IMA
concentrations later returned to pre-procedure levels
after 6 h. In contrast, the concentration of IMA in
patients receiving arterial reconstruction in the present
study increased by 43.2% for the patients having
bypass surgery and 42.2% for those receiving AAA
repair. This greater increase is likely to be due to the
larger volume of ischaemic tissue in these groups.
Interestingly, there was no apparent difference
between these two groups despite the bypass group
being subjected to ischaemia of only one limb and the
patients with AAA to ischaemia of the whole lower
torso. In addition, the levels of IMA remained
significantly elevated above baseline for up to 6 days
in patients receiving arterial surgery. The release of the
vascular clamps allows blood to re-enter the pre-
viously ischaemic limb(s) with the consequent pro-
duction of oxygen-derived free radicals from the
xanthine oxidase system and later from the recruit-
ment of neutrophils.21–23 These inflammatory
reactions, both locally and later systemically, persist
after the cessation of ischaemia and are likely to be
responsible for the sustained generation of IMA.24 Of
note is that the IMA concentrations in patients with
AAA were significantly greater at 24 and 48 h of
reperfusion, suggesting a greater ongoing
Skeletal Muscle and Ischaemia Modified Albumin 169inflammatory reaction compared with the single limb
revascularisation group.
The results of this proof-of-principle study suggest
that IMA does increase due to significant skeletal
muscle ischaemia and is not specific for ischaemic
myocardium. Further work is required to confirm this
finding and also to examine the effect of other
ischaemic tissues, such as bowel, on IMA production.
Perhaps the albumin cobalt binding assay will in time,
not only aid in the diagnosis of myocardial ischaemia,
but also conditions such as mesenteric ischaemia and
compartment syndrome, where the penalty for a
delayed or missed diagnosis is profound.Acknowledgements
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